MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

03 Aug 2023 Evaluate
The revenue slipped marginally during the June 2023 quarter. A decline of about Rs. 229.35 millions was observed as compared to Rs. 235.06 millions during the corresponding quarter last year.The Company has registered profit of Rs. 24.69  millions for the quarter ended June 2023, a growth of 7.63%  over Rs. 22.94 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 41.45 millions from 38.42 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 229.35 235.06 -2.43 229.35 235.06 -2.43 957.49 750.74 27.54
Other Income 0.12 1.53 -92.16 0.12 1.53 -92.16 2.38 1.84 29.35
PBIDT 41.45 38.42 7.89 41.45 38.42 7.89 184.46 164.39 12.21
Interest 0.16 0.47 -65.96 0.16 0.47 -65.96 1.33 4.54 -70.70
PBDT 41.29 37.95 8.80 41.29 37.95 8.80 183.13 159.85 14.56
Depreciation 8.31 7.30 13.84 8.31 7.30 13.84 32.33 32.81 -1.46
PBT 32.98 30.65 7.60 32.98 30.65 7.60 150.80 127.04 18.70
TAX 8.29 7.71 7.52 8.29 7.71 7.52 37.45 34.90 7.31
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.50 1.45 -134.48
PAT 24.69 22.94 7.63 24.69 22.94 7.63 113.35 92.14 23.02
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 18.07 16.34 10.57 18.07 16.34 10.57 19.26 21.90 -12.02
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..